Clinical trial
Opiate-sparing Post-operative Pain Control in Septorhinoplasty: A Prospective Randomized, Double Blind Clinical Trial
NCT06989866 is registered in ClinicalTrials.gov with United States Naval Medical Center, Portsmouth as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Opiate-sparing Post-operative Pain Control in Septorhinoplasty: A Prospective Randomized, Double Blind Clinical Trial
- Lead sponsor
- United States Naval Medical Center, Portsmouth
- Phase
- Phase 3
- Overall status
- Enrolling by invitation
- Start date
- December 1, 2024
- Completion date
- September 1, 2026
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.